We recently released a list Buy 11 best medical equipment stock now. In this article, we will explore other best medical device stocks purchased immediately by Danaher Corporation (NYSE:DHR).
CNBC reported on April 16 that Trump's tariffs are building a gap in the healthcare community. The first Trump administration has not imposed tariffs on medical equipment and protective equipment made in Mexico, China and Canada. But, to date, the industry has not received a probation on the president's latest duties. This leads to a division: Equipment manufacturers are backing down as they may face major challenges with tariffs. By contrast, PPE manufacturers will benefit from the barriers created by taxes, which is why they show no signs of pushback.
Therefore, the medical community is conducting a dichotomy when facing tariffs. CNBC reports that these responsibilities can also increase hospital costs, while patients ultimately reduce their chances of receiving intensive care and equipment. Scott Whitaker, CEO of Advamed, a trade group representing medical technology and equipment manufacturers, regarding the following:
“MedTech supply chain leaders are already reporting supply chain issues and we cannot afford to increase health care costs for patients or healthcare systems. The reality is that any increased costs will be largely borne by taxpayer-sponsored health programs like Medicare, Medicare, Medicaid, Medicaid and VA.”
Hospital trade groups have also expressed their concerns, warning that tariffs can reduce the quality of care. CNBC reported that Rick Pollack, CEO of the American Hospital Association, believes:
“AHA has and will continue to share with the government that the availability of these critical devices, many of which are internationally sourced, has the potential to undermine the potential of patient care. AHA continues to promote tariff exemptions on medical devices to ensure hospitals and health systems can continue to serve patients and communities.”
Please read also: Recession-resistant investment: Buy 10 best grocery store stocks now and 11 According to hedge funds, the most promising future stocks.
President Trump imposed a 25% tariff on imported goods from Mexico and Canada in February, and later delayed taxation on many items that comply with the U.S.-Mexican-Canada agreement. However, Chinese goods have not seen any probation yet. In fact, the new tax imposed by Trump in his second term puts the total tariff rate as high as 145%. While the current conditions are to raise prices to offset the rising tariffs, a range of hospitals and other organizations that purchase medical equipment cannot do so. As a result, these institutions may face higher cost complications at locked annual prices in current insurance coverage contracts.
Casey Hite, CEO of Aeroflow Health, a company that provides insurance-covered medical devices, said:
"With the level of tariffs we consider in China, businesses will completely disrupt these products … they can't transfer these fees to consumers. I think the most important thing we want to see is the runway or some predictability. Let's do this over the next 12 months, and the next two years, American organizations can be ready."
We filtered stock filters, financial media reports and ETFs to compile a list of 25 best medical device inventory and then selected the top 11 of the most hedge fund holders from the fourth quarter of 2024. We sourced hedge fund sentiment data from Insider Monkey's database. This list is sorted in ascending order of hedge fund sentiment.
Why are we interested in stocks that hedge funds to accumulate? The reason is simple: Our research shows that we can beat the market by mimicking the top stocks of the best hedge funds. Our quarterly newsletter strategy selects 14 small and large stocks every quarter, returning 363.5% since May 2014, exceeding 208 percentage points (See more details here).
A healthcare professional in a lab coat wearing a microscope looking at the slide under the camera.
Number of hedge fund holders: 101
Danaher Corporation (NYSE:DHR) designs, manufacturers and markets specialized, medical, industrial and commercial products and services. It operates through diagnostics, biotechnology, life sciences, and environmental and application solutions. The Life Diagnostics segment offers clinical tools, equipment, consumables and other services for diagnosing and treating diseases.
In a report released on April 23, Michael Ryskin of Bank of America Securities reiterated the buy rating of Darnach Corporation (NYSE: DHR) and set its target target at $230.00. The company's Q1 2025 results exceeded expectations, especially in the bioprocessing and CPHD respiratory sectors.
It also retains sales guidance for fiscal 2025 and improves its growth forecast for bioprocessing. These trends reflect their resilience in challenging market environments and confidence in market demand and operational capabilities.
According to analysts, Danaher Corporation (NYSE:DHR) can also further support the buy rating through strategic plans such as supply chain management and surcharges to cope with potential headwinds (such as tariffs).
Overall, DHR Ranked first On our inventory list of the best medical equipment to buy now. Although we acknowledge the potential of DHR as an investment, our belief is that certain AI stocks offer higher returns in a shorter time frame and achieve greater hope in this range. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for AI stocks that are more promising than DHR but have less than 5 times its earnings, check out our report Cheapest AI stocks.
Read the next article: Buy 20 Best AI Stocks Now and According to the billionaire, there are now 30 best stocks.
Disclosure: None. This article was originally published in Internal monkey.